• Users Online: 3601
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others


Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan

Chiang Tsung-Ta, Tang Hung-Jen, Chiu Cheng-Hsun, Chen Te-Li, Ho Mao-Wang, Lee Chen-Hsiang, Sheng Wang-Huei, Yang Ya-Sung

Year : 2016| Volume: 36| Issue : 6 | Page no: 229-233

   This article has been cited by
1 In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
Ming-Jen Sheu,Chi-Chung Chen,Ying-Chen Lu,Bo-An Su,Chun-Cheng Zhang,Shu-Shen Wang,Yin-Ching Chuang,Hung-Jen Tang,Chih-Cheng Lai
Antibiotics. 2020; 9(2): 77
[Pubmed]  [Google Scholar] [DOI]
2 Randomized Noninferiority Trial of Cefoperazone-Sulbactam versus Cefepime in the Treatment of Hospital-Acquired and Healthcare-Associated Pneumonia
Jien-Wei Liu,Yen-Hsu Chen,Wen-Sen Lee,Jung-Chung Lin,Ching-Tai Huang,Hsi-Hsun Lin,Yung-Ching Liu,Yin-Ching Chuang,Hung-Jen Tang,Yao-Shen Chen,Wen-Chien Ko,Min-Chi Lu,Fu-Der Wang
Antimicrobial Agents and Chemotherapy. 2019; 63(8)
[Pubmed]  [Google Scholar] [DOI]
3 The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms
Ping-Chin Chang,Chi-Chung Chen,Ying Chen Lu,Chih-Cheng Lai,Hui-Ling Huang,Yin-Ching Chuang,Hung-Jen Tang
Journal of Microbiology, Immunology and Infection. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article